The evaluation of doxorubicin-induced cardiotoxicity: Comparison of Doppler and tissue Doppler-derived myocardial performance index | Zendy

Selim Ayhan | Zendy; Kurtuluş Özdemir | Zendy; Mehmet Kayrak | Zendy; Ahmet Bacaksız | Zendy; Mehmet Akıf Vatankulu | Zendy; Önder Eren | Zendy; Fatih Koç | Zendy; Çetin Duman | Zendy; Hakan Güleç | Zendy; Kenan Demır | Zendy; Hatem Arı | Zendy; Osman Sönmez | Zendy; Hasan Gök | Zendy

Open Access

The evaluation of doxorubicin-induced cardiotoxicity: Comparison of Doppler and tissue Doppler-derived myocardial performance index

Author(s) -

Selim Ayhan,

Kurtuluş Özdemir,

Mehmet Kayrak,

Ahmet Bacaksız,

Mehmet Akıf Vatankulu,

Önder Eren,

Fatih Koç,

Çetin Duman,

Hakan Güleç,

Kenan Demır,

Hatem Arı,

Osman Sönmez,

Hasan Gök

Publication year - 2012

Publication title -

cardiology journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.573

H-Index - 33

eISSN - 1897-5593

pISSN - 1898-018X

DOI - 10.5603/cj.2012.0066

Subject(s) - doxorubicin , cardiotoxicity , medicine , cumulative dose , doppler effect , cardiology , correlation coefficient , doppler imaging , doppler echocardiography , chemotherapy , diastole , statistics , physics , mathematics , astronomy , blood pressure

Doxorubicin is a chemotherapeutic agent used in a wide spectrum of cancers. However, cardiotoxic effects have limited its clinical use. The early detection of doxorubicin-induced cardiotoxicity is crucial. The purpose of our study was to assess values of Doppler and tissue Doppler imaging (TDI)-derived myocardial performance index (MPI) in adult cancer patients receiving doxorubicin treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research